The Best Wake and Bake Cannabis Strains
If you love the morning ritual, Vibe by California has reviewed the best wake and bake cannabis strains here for you.
What makes a good morning strain? Most wake and bake users report they prefer a smooth Sativa to help promote alertness and an overall sense of well-being to start the day. We dig a little deeper to discover there are some great alternatives to inhaling that will give more long-lasting effects.
If you want to take advantage of wake and bake strains, you need to know a little about cannabis strain effects and how best to use them to get the experience you want. Read on and discover cannabis strains with the best potential use for waking up and staying productive all day long.
What does it mean to wake and bake – Waking and baking is a slang term for smoking marijuana first thing in the morning. It’s often reserved for those who like mornings with a side of cannabis or those who have a lot of work or other day-to-day responsibilities and don’t have time to smoke later on.
What types of weed are best for wake and bake – You can choose any strain of marijuana for a wake and bake sesh, just depends on the effects you’re looking for.
Sativa strains are generally more energizing than indica strains, which are often reserved for later in the day use to promote deep relaxation. Indica strains tend to have an overall body high effect, or type of sedation and are helpful when relieving stress or body aches and pain*. Hybrid strains have an abundant of different effects and uses, and navigating the hybrid strains takes a little patience but is well worth it to help you fine-tune the type of experience you want to have using cannabis.
A Review of 5 Cannabis Strains Popular for Early Morning Wake and Bake
Various factors go into choosing the best strain for your day. However, the time of day you want to feel, what you want to do, what you’ve eaten, and other factors play a role in deciding which cannabis strain to choose that will have the effect you’re going for.
There’s nothing like wake and bake to start out the day alert. Getting high in the morning is popular with people who know what strains of cannabis will make you alert and productive instead of sleepy and sedated. Finding the right weed strain for your wake and bake will produce the experience you want to have.
A brief survey of some wake and bake OG’s produced a list of early morning strains worth considering, if you haven’t already tried them.
Although it has numerous historical roots, Headband is best known for the cerebral effect that users liken to the sensation of using a headband. Additionally to the heady high, users have described feeling relaxed, ecstatic, and spacey.
Headband is a short and bushy plant during the vegetative phase that makes the most of the available area during the blooming cycle thanks to the usage of an OG Kush male to fertilize a Sour Diesel female by Amsterdam’s DNA Genetics. Small buds are produced by this strain, which benefits from vigorous training to increase plant output.
With genetics being derived from Sour Diesel, arguably one of the most potent OG cannabis strains and a perennial favorite, Headband tops our list as one of the best strains to get the morning buzz moving and baked in.
There are claims that Grapefruit Kush tends to produce a happy high, promoting creativity, and the feeling of being uplifted and relaxed. Grapefruit Kush is one of the top recommended strains by medical cannabis users and can be used therapeutically to soothe all types of symptoms and chronic ailments.
Grapefruit Kush’s genetics originated in Vancouver, BC, Canada at Next Generation Seed Company. Next Generation combined BC Kush and Grapefruit OG to form a super sweet and lemon citrus strain with a vibrant and uplifting aroma. Citrus stimulates and penetrates the sense of smell deeply and immediately promotes greater alertness.
Another Dutch breeder, Royal Queen Seeds created the hybrid strain known as Royal Haze. Royal Haze strain packs a powerful aroma punch with terpene notes of lemon, spice, and skunk. These aromas brighten the senses no matter what time of day!
Royal Haze is said to taste of cedar, pine, and lemony citrus. All being such deepy aromatic scents, it’s best enjoyed by inhaling deeply and letting the terpenes alert and awaken your senses naturally.
Royal Haze strain has a short seed to smoke range, maturing in only 6-8 weeks, making this a readily available, year round choice that’s great for wake and bake.
A popular parent strain for new hybrids, Jack Herer comes from the Dutch seed bank Sensi Seeds. Through the legacy cannabis days until now, Jack Herer strain has received nine first-place High Times Cannabis Cup honors.
Although its parentage is unknown, Jack Herer strain is usually believed to be a complicated cross between the cannabis strains Northern Lights #5, Shiva Skunk, and Haze. According to the survey, the Jack Herer strain has flavor notes of citrus, pine, oak, and spice. A nice blend for wake up calls.
So who the heck is Jack Herer and why is there a popular modern cannabis strain named after him? An illustrious cannabis campaigner and writer, Jack Herer wrote the 1985 novel “The Emperor Wears No Clothes.” The non-fiction book is a compilation put together by Herer, who took the advice of his friend, “Captain” Ed Adair, and began compiling tidbits of information about the cannabis plant and its many beneficial uses.
Orange Creamsicle lives up to its name, having powerful flavor notes and tasting like the orange and vanilla ice cream combo favorite with hints of fresh citrus scent.
Orange Creamsicle is a hybrid strain, created by the MTG Seeds team from Orange Crush and Juicy Fruit. The cultivar’s genetic ancestry notes includes deriving Orange Creamsisle strain genetics from Thai landrace and Blueberry, both of which are reported to have powerful uplifting properties.
Orange Creamsicle strain effects range from feelings of being energetic, euphoric and happy. So if you happen to wake up on the wrong side of the bed, this one can set you back on the right track quickly.
Why Just Wake and Bake? Edibles Make it Easy to Wake and Sip
On a side note, the method of consumption is worth considering when timing the effect onslaught is necessary. Smoking or vaporizing cannabis will provide an immediate onset and peak of effects (usually within 30 minutes).
Ingesting cannabis edibles of any kind, the effects can take up to two hours to kick in, but last much longer once it does. If you have time before your morning routine begins, try having a THC or CBD edible before stepping out. Edibles are a great option because they leave no marijuana “smell” after use and they provide a long-lasting effects without the need for constant dosing throughout the day.
Where to Find Wake and Bake Cannabis Strains
With so many new cannabis strains to choose from, it can be overwhelming to choose the best cannabis strain, even for the seasoned cannabis user. Heading to your local Vibe Dispensary can be help since the friendly budtenders are trained with in depth strain knowledge and know what cannabis products in the store make them available.
Wake and bake strains overall promote the feelings of well-being and alertness. Can promote creativity and an optimistic outlook, while dulling any body pain or discomfort. Our top wake and bake strain picks are a great place to start if you’re looking for an uplifting wake and bake experience. If you give any of our recommendations a try, let us know! We love hearing about your cannabis experiences with any of the cannabis products available at Vibe.
Information on this website is shared for educational and informational purposes only.
The information on this website has not been evaluated by the Food & Drug Administration or any other medical body. We do not aim to diagnose, treat, cure or prevent any illness or disease. Consult a medical doctor before acting on any information gathered on this website, especially if you are pregnant, nursing, taking medication, or have a pre-existing or other medical condition.
For further reading about CBD products, please refer to the references below.
Papers of particular interest on CBD, published recently, have been outlined and links provided to medical studies and research available.
1.•• Bridgeman MB, Abazia DT. Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting. P T. 2017;42(3):180–8 (excellent review on Cannabinoids focused on pharmacology).
1.•• Vučković S, Srebro D, Vujović KS, Vučetić Č, Prostran M. Cannabinoids and Pain: New Insights From Old Molecules. Front Pharmacol. 2018;9:1259 (excellent review on Cannabinoids and Pain).
1. Russo EB. Cannabinoids in the management of difficult to treat pain. There Clin Risk Manag. 2008;4(1):245–59.
1.Costa B, Trovato AE, Comelli F, Giagnoni G, Colleoni M. The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain. Eur J Pharmacol. 2007;556(1–3):75–83.
1.Kumar RN, Chambers WA, Pertwee RG. Pharmacological actions and therapeutic uses of cannabis and cannabinoids. Anaesthesia. 2001;56(11):1059–68.
1.Pacher P, Bátkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev. 2006;58(3):389–462.
1.Zou S, Kumar U. Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System. Int J Mol Sci. 2018;19(3):833 Published 2018 Mar 13.
1.Anand P, Whiteside G, Fowler CJ, Hohmann AG. Targeting CB2 receptors and the endocannabinoid system for the treatment of pain. Brain Res Rev. 2009;60(1):255–66.
1.Laprairie RB, Bagher AM, Kelly ME, Denovan-Wright EM. Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. Br J Pharmacol. 2015;172(20):4790–805.
1.Hammell DC, Zhang LP, Ma F, , Abshire SM, McIlwrath S, Stinchcomb AL, Westlund KNet al. Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis. Eur J Pain. 2016;20(6):936–948.
1.Philpott HT, OʼBrien M, McDougall JJ. Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis. Pain. 2017;158(12):2442–51.
1.Malfait AM, Gallily R, Sumariwalla PF, , Malik AS, Andreakos E, Mechoulam R, Feldmann Met al. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci U S A. 2000;97(17):9561–9566.
1.Babalonis S, Haney M, Malcolm RJ, , Lofwall MR, Votaw VR, Sparenborg S, Walsh SLet al. Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers. Drug Alcohol Depend. 2017;172:9–13.
1.Sekar K, Pack A. Epidiolex as adjunct therapy for treatment of refractory epilepsy: a comprehensive review with a focus on adverse effects. F1000Res. 2019;8:F1000 Faculty Rev-234.
1.Russo E, Guy GW. A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Med Hypotheses. 2006;66(2):234–46.
1.Vermersch P, Trojano M. Tetrahydrocannabinol:Cannabidiol Oromucosal Spray for Multiple Sclerosis-Related Resistant Spasticity in Daily Practice. Eur Neurol. 2016;76(5–6):216–26. https://doi.org/10.1159/000449413.
1.Nielsen S, Germanos R, Weier M, Pollard J, Degenhardt L, Hall W, et al. The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews. Curr Neurol Neurosci Rep. 2018;18(2):8.
1.Ferrè L, Nuara A, Pavan G, Radaelli M, Moiola L, Rodegher M, et al. Efficacy and safety of nabiximols (Sativex(®)) on multiple sclerosis spasticity in a real-life Italian monocentric study. Neurol Sci. 2016;37(2):235–42.
1.Johnson JR, Lossignol D, Burnell-Nugent M, Fallon MT. An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics. J Pain Symptom Manage. 2013;46(2):207–18.
1.Portenoy RK, Ganae-Motan ED, Allende S, Yanagihara R, Shaiova L, Weinstein S, et al. Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial. J Pain. 2012;13(5):438–49.
1.•• Lichtman AH, Lux EA, McQuade R, Rossetti S, Sanchez R, Sun W, et al. Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain. J Pain Symptom Manage. 2018;55(2):179–188.e1 (excellent study on Cannabinoids and Cancer Pain).
1.Nurmikko TJ, Serpell MG, Hoggart B, Toomey PJ, Morlion BJ, Haines D. Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial. Pain. 2007;133(1–3):210–20.
1.Blake DR, Robson P, Ho M, Jubb RW, McCabe CS. Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology (Oxford). 2006;45(1):50–2.
1.Cannabinoid Buccal Spray for Chronic Non-Cancer or Neuropathic Pain: A Review of Clinical Effectiveness, Safety, and Guidelines. 2016 Sep 21;. Review.
2.Moulin D, Boulanger A, Clark AJ, Clarke H, Dao T, Finley GA, et al. Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society. Pain Res. Manag. 19:328–35.
1.Darkovska-Serafimovska M, Serafimovska T, Arsova-Sarafinovska Z, Stefanoski S, Keskovski Z, Balkanov T. Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases. J Pain Res. 2018;11:837–42.
1.The FDA Warning Letters and Test Results for Cannabidiol-Related Products. https://www.fda.gov/news-events/public-health-focus/warning-letters-and-test-results-cannabidiol-related-products.
Research paper available in PDF form for download here: fphar-08-00269
1.Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders
Alline C. Campos1*, Manoela V. Fogaça1, Franciele F. Scarante1, Sâmia R. L. Joca2, Amanda J. Sales2, Felipe V. Gomes3, Andreza B. Sonego1, Naielly S. Rodrigues1, IsmaelGalve-Roperh4,5 andFranciscoS.Guimarães1
1 Department of Pharmacology, Centre for Interdisciplinary Research on Applied Neurosciences (NAPNA), School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil, 2 Department of Physical and Chemical, School of Pharmaceutical Science of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil, 3 Department of Neuroscience, University of Pittsburgh, Pittsburgh, PA, United States, 4 Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University, Madrid, Spain, 5 Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Instituto de Universitario de Investigación en Neuroquímica and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.
Frontiers in Pharmacology, published: 23 May 2017 doi: 10.3389/fphar.2017.00269